Annual Total Long Term Liabilities
$111.00 K
+$39.90 K+56.12%
December 31, 2023
Summary
- As of February 7, 2025, BGLC annual total long term liabilities is $111.00 thousand, with the most recent change of +$39.90 thousand (+56.12%) on December 31, 2023.
- During the last 3 years, BGLC annual total long term liabilities has risen by +$31.50 thousand (+39.62%).
- BGLC annual total long term liabilities is now at all-time high.
Performance
BGLC Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$192.00 K
-$2600.00-1.34%
September 30, 2024
Summary
- As of February 7, 2025, BGLC quarterly total long term liabilities is $192.00 thousand, with the most recent change of -$2600.00 (-1.34%) on September 30, 2024.
- Over the past year, BGLC quarterly long term liabilities has dropped by -$2600.00 (-1.34%).
- BGLC quarterly long term liabilities is now -1.34% below its all-time high of $194.60 thousand, reached on June 30, 2024.
Performance
BGLC Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BGLC Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +56.1% | -1.3% |
3 y3 years | +39.6% | +189.2% |
5 y5 years | +64.7% | +189.2% |
BGLC Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +68.4% | -1.3% | +383.6% |
5 y | 5-year | at high | +93.7% | -1.3% | +383.6% |
alltime | all time | at high | +93.7% | -1.3% | +383.6% |
BioNexus Gene Lab Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $192.00 K(-1.3%) |
Jun 2024 | - | $194.60 K(+93.1%) |
Mar 2024 | - | $100.80 K(-9.2%) |
Dec 2023 | $111.00 K(+56.1%) | $111.00 K(-17.0%) |
Sep 2023 | - | $133.70 K(+127.8%) |
Jun 2023 | - | $58.70 K(-11.6%) |
Mar 2023 | - | $66.40 K(-6.6%) |
Dec 2022 | $71.10 K(+7.9%) | $71.10 K(+79.1%) |
Sep 2022 | - | $39.70 K(-10.8%) |
Jun 2022 | - | $44.50 K(-28.9%) |
Mar 2022 | - | $62.60 K |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $65.90 K(-17.1%) | - |
Dec 2021 | - | $65.90 K(+35.6%) |
Sep 2021 | - | $48.60 K(-17.8%) |
Jun 2021 | - | $59.10 K(-16.4%) |
Mar 2021 | - | $70.70 K(-11.1%) |
Dec 2020 | $79.50 K(+38.7%) | $79.50 K(+82.8%) |
Sep 2020 | - | $43.50 K(-1.4%) |
Jun 2020 | - | $44.10 K(-5.8%) |
Mar 2020 | - | $46.80 K(-18.3%) |
Dec 2019 | $57.30 K(-15.0%) | $57.30 K |
Dec 2018 | $67.40 K | - |
FAQ
- What is BioNexus Gene Lab annual total long term liabilities?
- What is the all time high annual total long term liabilities for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual total long term liabilities year-on-year change?
- What is BioNexus Gene Lab quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly long term liabilities year-on-year change?
What is BioNexus Gene Lab annual total long term liabilities?
The current annual total long term liabilities of BGLC is $111.00 K
What is the all time high annual total long term liabilities for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual total long term liabilities is $111.00 K
What is BioNexus Gene Lab annual total long term liabilities year-on-year change?
Over the past year, BGLC annual total long term liabilities has changed by +$39.90 K (+56.12%)
What is BioNexus Gene Lab quarterly total long term liabilities?
The current quarterly long term liabilities of BGLC is $192.00 K
What is the all time high quarterly long term liabilities for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly total long term liabilities is $194.60 K
What is BioNexus Gene Lab quarterly long term liabilities year-on-year change?
Over the past year, BGLC quarterly total long term liabilities has changed by -$2600.00 (-1.34%)